newsfilter
← Latest News
ACCESS Newswire·

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Revenue increased 31% for the quarter compared to same period prior yearPositive cash flows from operations of $0.35 million for the quarterNet loss improved 59% for the quarter compared to same period prior yearNet loss